Rallybio Corporation
RLYB
$14.35
$0.322.28%
NASDAQ
| 12/31/2025 | 09/30/2025 | 06/30/2025 | 03/31/2025 | 12/31/2024 | |
|---|---|---|---|---|---|
| Net Income | -136.54% | 265.06% | -2.80% | 14.53% | 3.68% |
| Total Depreciation and Amortization | -91.43% | 34.62% | -7.14% | -6.67% | -6.25% |
| Total Amortization of Deferred Charges | -- | -- | -- | -- | -- |
| Total Other Non-Cash Items | 103.16% | -1,325.17% | -22.52% | 8.62% | -10.59% |
| Change in Net Operating Assets | 141.60% | -163.33% | 85.25% | -229.73% | 79.14% |
| Cash from Operations | 28.56% | 21.83% | 17.89% | -3.48% | 27.19% |
| Capital Expenditure | -- | -- | -- | -- | -- |
| Sale of Property, Plant, and Equipment | -- | -- | -- | -- | -- |
| Cash Acquisitions | -- | -- | -- | -- | -- |
| Divestitures | -- | -- | -- | -- | -- |
| Other Investing Activities | -86.57% | 863.00% | -72.61% | 804.45% | -107.08% |
| Cash from Investing | -86.57% | 863.00% | -72.61% | 804.45% | -107.08% |
| Total Debt Issued | -- | -- | -- | -- | -- |
| Total Debt Repaid | -- | -- | -- | -- | -- |
| Issuance of Common Stock | -- | -100.00% | -- | -- | -- |
| Repurchase of Common Stock | -- | -- | -- | -- | -- |
| Issuance of Preferred Stock | -- | -- | -- | -- | -- |
| Repurchase of Preferred Stock | -- | -- | -- | -- | -- |
| Total Dividends Paid | -- | -- | -- | -- | -- |
| Other Financing Activities | -- | -- | -- | -- | 100.00% |
| Cash from Financing | -- | -100.00% | -- | -- | 263.64% |
| Foreign Exchange rate Adjustments | -- | -- | -- | -- | -- |
| Miscellaneous Cash Flow Adjustments | -- | -- | -- | -- | -- |
| Net Change in Cash | -103.30% | 525.14% | -708.90% | 107.67% | -232.00% |